IP Library Granted Patent US 10,166,195
Granted Patent B2
US 10,166,195 · App. 15/123,479 · Granted Jan 1, 2019

Vaccine delivery systems using yeast cell wall particles

Inventor: Thomas E. Wagner (Greenville, SC)
Assignee: Orbis Health Solutions, LLC
A61K9/5068A61K9/19A61K31/70A61K31/7088A61K39/0011A61K39/39C12N1/16A61K2039/5154A61K2039/55561A61K2039/55572A61K2039/55588A61K2039/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,166,195
App. No.
15/123,479
Granted
Jan 1, 2019
Kind
B2
Abstract

The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making prophylactic and therapeutic vaccines.

Claims (7)

1. A method for treating cancer, comprising administering to a subject a composition comprising (i) a yeast cell wall particle; (ii) a silicate, and (iii) an exogenous biological material loaded within the particle, wherein the biological material comprises a tumor lysate, and wherein the yeast cell wall particle is coated with the silicate.

2. The method of claim 1 , wherein the cancer is selected from the group consisting of breast cancer, small cell lung cancer, non-small cell lung cancer, glioma, medulloblastoma, neuroblastoma, Wilms tumors, rhabdomyosarcoma, osteosarcoma, liver cancer, pancreatic cancer, melanoma, prostate cancer and ocular melanoma.

3. The method of claim 1 , wherein the silicate is selected from the group consisting of tetraethylorthosilicate, tetramethylorthosilicate, tetrapropylorthosilicate, and tetrabutylorthosilicate.

4. The method of claim 1 , wherein the biological material loaded particle is further incubated with an isolated dendritic cell prior to administration.

5. The method of claim 1 , wherein the composition further comprises one or more adjuvants, excipients, and preservatives.

6. The method of claim 5 , wherein the adjuvant is monophosphoryl lipid A or a CpG oligonucleotide.

7. The method of claim 5 , wherein the one or more adjuvants are loaded within the yeast cell wall particle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2026
From: ORBIS HEALTH SOLUTIONS, LLC
To: ELIOS HOLDINGS, LLC
Reel/Frame 074417/0948 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: WAGNER, THOMAS E.
To: ORBIS HEALTH SOLUTIONS, LLC
Reel/Frame 047622/0802 →
Continuity (3)
Provisional Application 61948503 · Mar 5, 2014
Provisional Application 62060124 · Oct 6, 2014
Related Publication 20170065532A1 · Mar 9, 2017